Clinical Indication

Haemolytic anaemia in adults and paediatric patients 12 years of age and older with sickle cell disease


Under the EAMS scheme

Date of classification

July 2022


Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.